Nephro Care India Ltd

₹ 83.0 -3.43%

23 Oct - close price

nephrocareindia.com NSE - SME: NEPHROCARE

About

Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes
in the treatment of kidney- related diseases^[1]

Key Points

Business Overview:^[1]^[2]
NCIL provides comprehensive medical services for renal patients as a one-stop treatment center in Kolkata. It offers clinical and lifestyle solutions for renal insufficiency, covering lifestyle, physiological, and spiritual wellness. The company specializes in non-invasive services.

Website NSE - SM

Market Cap ₹ 137 Cr.
Current Price ₹ 83.0
High / Low ₹ 156 / 50.0
Stock P/E 27.0
Book Value ₹ 34.5
Dividend Yield 0.00 %
ROCE 7.90 %
ROE 5.07 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has a low return on equity of 9.53% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty SME Emerge

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2025	Dec 2025	Mar 2026	Jun 2026
	17.33	22.66	26.75	29.19
	16.73	20.75	24.73	25.57
Operating Profit	0.60	1.91	2.02	3.62
OPM %	3.46%	8.43%	7.55%	12.40%
	0.05	0.08	0.83	0.22
Interest	0.14	0.03	-0.01	0.03
Depreciation	1.16	1.40	1.56	1.19
Profit before tax	-0.65	0.56	1.30	2.62
Tax %	0.00%	25.00%	23.08%	38.17%
	-0.65	0.42	1.00	1.61
EPS in Rs	-0.39	0.25	0.61	0.98
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0.54	1.82	3.42	17.09	27.23	46.03	88.74
	0.52	1.67	3.28	13.66	20.76	40.16	80.42
Operating Profit	0.02	0.15	0.14	3.43	6.47	5.87	8.32
OPM %	3.70%	8.24%	4.09%	20.07%	23.76%	12.75%	9.38%
	0.01	0.01	-0.01	0.00	0.28	1.53	1.55
Interest	0.04	0.03	0.02	0.07	0.09	0.11	0.16
Depreciation	0.00	0.01	0.11	0.78	0.53	2.46	5.07
Profit before tax	-0.01	0.12	0.00	2.58	6.13	4.83	4.64
Tax %	0.00%	25.00%		7.75%	28.06%	24.64%	27.37%
	-0.01	0.09	-0.01	2.37	4.41	3.64	3.37
EPS in Rs	-0.50	4.50	-0.01	2.37	3.71	2.21	2.04
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	118%
3 Years:	73%
TTM:	93%

Compounded Profit Growth
10 Years:	%
5 Years:	99%
3 Years:	6%
TTM:	24%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	-40%

Return on Equity
10 Years:	%
5 Years:	11%
3 Years:	10%
Last Year:	5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.01	0.01	0.50	0.50	11.90	16.49	16.49
Reserves	0.07	0.01	0.00	2.03	3.12	37.00	40.37
	0.40	0.69	2.54	2.48	0.00	0.00	0.00
	0.30	0.42	1.60	3.25	5.94	14.79	15.81
Total Liabilities	0.78	1.13	4.64	8.26	20.96	68.28	72.67
	0.45	0.06	1.39	3.01	4.74	31.48	34.01
CWIP	0.00	0.45	1.90	0.00	0.86	0.61	0.53
Investments	0.24	0.00	0.00	2.00	6.51	18.58	11.81
	0.09	0.62	1.35	3.25	8.85	17.61	26.32
Total Assets	0.78	1.13	4.64	8.26	20.96	68.28	72.67

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0.23	0.62	4.12	0.91	7.24	2.21
	-0.06	-2.81	-2.33	-7.54	-39.83	-0.48
	0.28	2.32	-0.08	5.60	35.96	0.00
Net Cash Flow	0.44	0.13	1.71	-1.03	3.37	1.73
Free Cash Flow	0.16	-2.28	3.62	-2.38	-22.56	-5.59
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	133%	493%	121%	50%	141%	48%

Ratios

Standalone / View Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	0.00	0.00	20.28	0.85	2.01	25.61	24.84
Inventory Days		8.83	41.93	35.25	14.07	34.38	31.68
Days Payable		94.19	113.45	69.03	75.17	107.32	92.84
Cash Conversion Cycle	0.00	-85.36	-51.24	-32.93	-59.09	-47.33	-36.31
Working Capital Days	-168.98	-88.24	-124.87	-56.81	-36.86	-51.15	-4.07
ROCE %		25.21%	1.60%	65.84%	60.41%	11.27%	7.90%

Insights

In beta

Mar 2024

Mar 2025

Mar 2026

Permanent employees
employees

xxx	xxx	xxx
x	xxx
x.xx	xx.xx
x	x
xx.xx	xx.xx
xx,xxx	x,xxx
	xx
	xxx

Please log in to see hidden values.

Hospital bed capacity
beds

IPD revenue mix
%

Number of clinics
clinics

OPD revenue mix
%

Patients treated
patients

Hospital bed occupancy
%

OT procedures
procedures

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Sep 2024	Dec 2024	Mar 2025	Sep 2025	Mar 2026	Jun 2026	Sep 2026
	61.38%	61.38%	61.44%	61.47%	61.71%	61.71%	61.71%
	3.92%	4.06%	3.50%	3.47%	0.73%	0.96%	0.73%
	4.82%	3.41%	2.24%	1.04%	1.30%	1.29%	0.86%
	29.87%	31.14%	32.82%	34.02%	36.27%	36.03%	36.71%
No. of Shareholders	852	1,077	1,391	1,644	1,845	1,900	1,946

	Mar 2025	Mar 2026	Sep 2026
	61.44%	61.71%	61.71%
	3.50%	0.73%	0.73%
	2.24%	1.30%	0.86%
	32.82%	36.27%	36.71%
No. of Shareholders	1,391	1,845	1,946

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Concalls

Aug 2025

Transcript

AI Summary
PPT